Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07533045 · ClinicalTrials.gov registry record · NA
Effects of Paraxanthine Supplementation on eSport Performancre
A NA study, sponsored by Lindenwood University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07533045 is a NA study that has completed, run by Lindenwood University. The registered enrollment target is 60 participants.
The verdict
NCT07533045, a NA study, has completed, sponsored by Lindenwood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will evaluate the effects of daily paraxanthine supplementation on electronic gaming performance, cognitive function, sleep quality, and autonomic responses in healthy adult gamers. Participants will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group study and assigned to receive either paraxanthine or placebo daily for 6 weeks. Outcome measures will be assessed at baseline, Week 3, and Week 6 and will include electronic gaming performance, cognitive function, visual analog scale ratings, sleep quality questionnaires, hemodynamic responses, and heart rate variability. The study is designed to determine whether paraxanthine supplementation improves performance and selected physiological and psychological outcomes during prolonged electronic gaming sessions.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Paraxanthine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-15 |
| Est. Completion | 2025-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07533045
The ClinicalTrials.gov registry entry for NCT07533045 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lindenwood University, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07533045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07533045 about?
NCT07533045 is a clinical study titled "Effects of Paraxanthine Supplementation on eSport Performancre". This study will evaluate the effects of daily paraxanthine supplementation on electronic gaming performance, cognitive function, sleep quality, and autonomic responses in healthy adult gamers. Participants will be enrolled in a randomized, double-blind, placebo-controlled, parallel-group study and a...
What is the current status of trial NCT07533045?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-15. Estimated completion is 2025-04-14.
What interventions are being tested in trial NCT07533045?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Paraxanthine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07533045?
This trial is sponsored by Lindenwood University, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.